USPTO serial 76399117
IMMUNODRUGS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FRENCH, CURTIS W
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with IMMUNODRUGS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
8952 Zurich-Schlieren, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tracy-Gene G. Durkin, Esq.
TRACY-GENE G DURKIN ESQ STERNE, KESSLER, GOLDSTEIN & FOX PLLC1100 NEW YORK AVE N WWASHINGTON, DC 20005-3934UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations, namely, antibiotics, vaccines and medicines for the treatment of immunological and hematological disorders, diseases affecting the immune system, allergies, inflammations, cancer, cardiovascular, and metabolic diseases, nervous system disorders, infectious diseases, respiratory diseases, bone diseases, and ailments associated with transplantation, all for use by humans and animals, namely, domestic, farm and wild animals; dietary supplements for medical use; sanitary preparations for medical use, namely, antibacterial, antiviral and antifungal agents for the elimination or reduction of germs, bacteria, viruses and fungi | ACTIVE | — |
| 042 | Scientific research in the field of biotechnology; technical consultation and research in the field of biotechnology; industrial research in the field of biotechnology, namely, for the identification and production of proteins and vaccines; development of new technologies for others in the field of biotechnology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 9, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 10, 2003 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Oct 23, 2003 | CFIT | CASE FILE IN TICRS | — |
| Apr 16, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 14, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Feb 21, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2003 | PAPER RECEIVED | — | |
| Aug 22, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 16, 2002 | DOCK | ASSIGNED TO EXAMINER | — |